Freenome Stock
Freenome is a health technology company using accurate, accessible and non-invasive disease screenings to proactively treat cancer and other diseases at their most manageable stages. Freenome does this through a fusion of machine learning, biology and computer science.
Sign up for SecondMarket™ to view the market and buy or sell Freenome Stock
Buy + SellFreenome Funding
Sign up to gain insights into Freenome funding history, including the funding round, time period, and amount raised.
Sign Up to Unlock the Data| Date | Financing Round | Amount | Price per share* | Valuation* |
|---|---|---|---|---|
| Feb 15, 2024 | Series F | 254.00M | ||
| Jan 11, 2022 | Series E | 290.00M | ||
| Nov 22, 2021 | Series D | 243.00M | ||
| Aug 14, 2020 | Series C | 270.00M | ||
| Jun 24, 2019 | Series B | 160.00M | ||
| Aug 14, 2017 | Series A | 8.05M | ||
| Feb 23, 2017 | Series A | 63.95M | ||
| May 23, 2016 | Series Seed | 5.55M |
See Freenome Valuations + Financials
*Sample data + company shown for illustrative purposes only
Gain insights Into Freenome Stock Valuation + Share Prices
View real-time Tape D™ data on Freenome stock including most recent valuation and historical share price information.
Are you an institutional investor or employee shareholder? Sign up to the SecondMarket™ trading platform.
Get Started
Freenome Management Team
Director
Randal Scott
Co-Founder, COO, Director
Riley Ennis
Co-Founder, Chief Growth Officer
Charles Roberts
Director
Peter Kolchinsky
Chief Scientific Officer
Jimmy Lin
CEO, Director
Mike Nolan
Co-Founder, Director
Gabriel Otte
Director
Amir Nashat
Director
Ellen Hukkelhoven
Director
Vijay Pande
Freenome Major Investors
Charles River Ventures (CRV)
T. Rowe Price Associates, Inc.
T. Rowe Price Associates, Inc.
Catalio Capital Management, LP
Catalio Capital Management, LP
Novartis, Inc.
Novartis, Inc.
The Founders Fund
Section 32
Soleus Capital Management
Cormorant Capital
Rock Springs Capital
Data Collective
EcoR1 Capital
Janus Henderson
Kaiser Permanente Ventures
F. Hoffmann-La Roche AG
Bain Capital Venture Partners LLC
Polaris Partners
Artis Ventures
Andreessen Horowitz LLC; AKA: A16Z
Farallon Capital Management LLC
RA Capital Management LLC
Google Ventures (GV)
Asset Management Ventures
Spectrum 28 Capital
Innovation Endeavors LLC
BrightEdge
Verily Life Sciences LLC
Fidelity Management & Research Company
Perceptive Advisors, LLC
Perceptive Advisors, LLC
Global Venture Capital, Inc.
Global Venture Capital, Inc.
Sands Capital Management LLC
Roche Venture Fund
Colorectal Cancer Alliance
Third Kind Venture Capital
Cormorant Asset Management
Ridgeback Capital
DCVC
Learn More About Freenome Stock
Buy Freenome Stock
01Sell Freenome Stock
02Freenome Stock Price
03Freenome Stock Ticker Symbol
04Criteria to Sell Freenome Stock
05Criteria to Buy or Invest in Freenome Stock
06Freenome Stock Settlement
07Freenome IPO
08*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
Sign up for SecondMarket™ to view the market and buy or sell Freenome Stock
Buy + Sell*All trademarks are the property of their respective owner(s). Unless expressly stated otherwise, companies listed on this site are not sponsoring, endorsing, or otherwise affiliated with, Nasdaq Private Market, LLC, and none of the statements on this website should be attributed to a listed company.
